Teriparatide (PTH 1‐34) Treatment Increases Peripheral Hematopoietic Stem Cells in Postmenopausal Women

Cells of the osteoblast lineage play an important role in regulating the hematopoietic stem cell (HSC) niche and early B‐cell development in animal models, perhaps via parathyroid hormone (PTH)‐dependent mechanisms. There are few human clinical studies investigating this phenomenon. We studied the impact of long‐term daily teriparatide (PTH 1‐34) treatment on cells of the hematopoietic lineage in postmenopausal women. Twenty‐three postmenopausal women at high risk of fracture received teriparatide 20 mcg sc daily for 24 months as part of a prospective longitudinal trial. Whole blood measurements were obtained at baseline, 3, 6, 12, and 18 months. Flow cytometry was performed to identify hematopoietic subpopulations, including HSCs (CD34+/CD45(moderate); ISHAGE protocol) and early transitional B cells (CD19+, CD27‐, IgD+, CD24[hi], CD38[hi]). Serial measurements of spine and hip bone mineral density (BMD) as well as serum P1NP, osteocalcin, and CTX were also performed. The average age of study subjects was 64 ± 5 years. We found that teriparatide treatment led to an early increase in circulating HSC number of 40% ± 14% (p = 0.004) by month 3, which persisted to month 18 before returning to near baseline by 24 months. There were no significant changes in transitional B cells or total B cells over the course of the study period. In addition, there were no differences in complete blood count profiles as quantified by standard automated flow cytometry. Interestingly, the peak increase in HSC number was inversely associated with increases in bone markers and spine BMD. Daily teriparatide treatment for osteoporosis increases circulating HSCs by 3 to 6 months in postmenopausal women. This may represent a proliferation of marrow HSCs or increased peripheral HSC mobilization. This clinical study establishes the importance of PTH in the regulation of the HSC niche within humans. © 2014 American Society for Bone and Mineral Research.

[1]  C. Panaroni,et al.  Interactions Between B Lymphocytes and the Osteoblast Lineage in Bone Marrow , 2013, Calcified Tissue International.

[2]  Hang Lee,et al.  Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial , 2013, The Lancet.

[3]  R. Baron,et al.  Parathyroid Hormone (PTH)/PTH-related Peptide Type 1 Receptor (PPR) Signaling in Osteocytes Regulates Anabolic and Catabolic Skeletal Responses to PTH* , 2013, The Journal of Biological Chemistry.

[4]  R. Baron,et al.  Myelopoiesis is regulated by osteocytes through Gsα-dependent signaling. , 2013, Blood.

[5]  R. Taichman,et al.  The effects of zoledronic acid in the bone and vasculature support of hematopoietic stem cell niches , 2013, Journal of cellular biochemistry.

[6]  E. Shpall,et al.  Phase II trial of parathyroid hormone after double umbilical cord blood transplantation. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  E. Hsiao,et al.  Activated Gs signaling in osteoblastic cells alters the hematopoietic stem cell niche in mice. , 2012, Blood.

[8]  M. Selig,et al.  Intermittent parathyroid hormone administration converts quiescent lining cells to active osteoblasts , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  L. Calvi,et al.  Osteoblastic expansion induced by parathyroid hormone receptor signaling in murine osteocytes is not sufficient to increase hematopoietic stem cells. , 2012, Blood.

[10]  Lei Ding,et al.  Endothelial and perivascular cells maintain haematopoietic stem cells , 2011, Nature.

[11]  C. Schaniel,et al.  Wnt-inhibitory factor 1 dysregulation of the bone marrow niche exhausts hematopoietic stem cells. , 2011, Blood.

[12]  Anita H. Undale,et al.  Effects of intermittent parathyroid hormone treatment on osteoprogenitor cells in postmenopausal women. , 2011, Bone.

[13]  N. Horwood,et al.  Inhibition of osteoclast function reduces hematopoietic stem cell numbers in vivo. , 2011, Blood.

[14]  I. Sanz,et al.  Novel Human Transitional B Cell Populations Revealed by B Cell Depletion Therapy1 , 2009, The Journal of Immunology.

[15]  A. McMahon,et al.  Osteoblastic regulation of B lymphopoiesis is mediated by Gsα-dependent signaling pathways , 2008, Proceedings of the National Academy of Sciences.

[16]  R. David,et al.  Parathyroid hormone effectively induces mobilization of progenitor cells without depletion of bone marrow. , 2008, Experimental hematology.

[17]  M. Bouxsein,et al.  Control of Bone Mass and Remodeling by PTH Receptor Signaling in Osteocytes , 2008, PloS one.

[18]  D. Scadden,et al.  Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo. , 2008, Cell stem cell.

[19]  M. Konopleva,et al.  Phase I trial of parathyroid hormone to facilitate stem cell mobilization. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[20]  Younghun Jung,et al.  Osteoblasts support B-lymphocyte commitment and differentiation from hematopoietic stem cells. , 2007, Blood.

[21]  D. Scadden,et al.  Therapeutic targeting of a stem cell niche , 2007, Nature Biotechnology.

[22]  R. Jilka,et al.  Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. , 2005, Endocrinology.

[23]  D. Rowe,et al.  Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. , 2004, Blood.

[24]  D. Scadden,et al.  Osteoblastic cells regulate the haematopoietic stem cell niche , 2003, Nature.

[25]  S. Nilsson,et al.  Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches. , 2001, Blood.

[26]  D. Sutherland.  Assessment of peripheral blood stem cell grafts by CD34+ cell enumeration: toward a standardized flow cytometric approach. , 1996, Journal of hematotherapy.

[27]  R. Turner,et al.  Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. , 1995, Endocrinology.

[28]  Richard Bruick.  SUPPLEMENTAL EXPERIMENTAL PROCEDURES , 2012 .